Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 23,010
-195 (-0.84%)
Aug 31, 2026, 3:30 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 294.24 billion as of August 31, 2026. Its market cap has increased by 70.43% in one year.
Market Cap
294.24B
Enterprise Value
296.49B
Revenue
23.72B
Ranking
n/a
PE Ratio
59.11
Stock Price
23,010.00
ChartMarket Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 294.24B, an increase of 87,697.23%. That is a compound annual growth rate of 30.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 294.24B | 50.98% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 494.80B |
| Gland Pharma | 476.42B |
| Ajanta Pharma | 444.40B |
| Emcure Pharmaceuticals | 354.59B |
| Wockhardt | 321.26B |
| Piramal Pharma | 290.22B |
| Eris Lifesciences | 182.19B |
| Cohance Lifesciences | 172.12B |